Rani Athota

1.4k total citations
11 papers, 806 citations indexed

About

Rani Athota is a scholar working on Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rani Athota has authored 11 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Infectious Diseases and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rani Athota's work include Influenza Virus Research Studies (10 papers), Respiratory viral infections research (8 papers) and Viral gastroenteritis research and epidemiology (2 papers). Rani Athota is often cited by papers focused on Influenza Virus Research Studies (10 papers), Respiratory viral infections research (8 papers) and Viral gastroenteritis research and epidemiology (2 papers). Rani Athota collaborates with scholars based in United States and Netherlands. Rani Athota's co-authors include Matthew J. Memoli, Lindsay Czajkowski, Jeffery K. Taubenberger, Tyler Bristol, Susan Reed, Alison Han, Richard T. Davey, Pamela A. Shaw, John H. Powers and Adriana Cervantes-Medina and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and mBio.

In The Last Decade

Rani Athota

11 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rani Athota United States 9 579 305 165 86 74 11 806
Lindsay Czajkowski United States 10 605 1.0× 322 1.1× 176 1.1× 94 1.1× 78 1.1× 15 850
Susan Reed United States 9 442 0.8× 237 0.8× 136 0.8× 76 0.9× 65 0.9× 10 629
Alison Han United States 14 500 0.9× 293 1.0× 217 1.3× 101 1.2× 51 0.7× 24 811
Tyler Bristol United States 9 597 1.0× 262 0.9× 169 1.0× 99 1.2× 62 0.8× 12 785
Monika Redlberger‐Fritz Austria 15 480 0.8× 245 0.8× 84 0.5× 59 0.7× 52 0.7× 44 655
Rutger M. Schepp Netherlands 19 567 1.0× 315 1.0× 154 0.9× 42 0.5× 49 0.7× 37 931
John Treanor United States 8 790 1.4× 264 0.9× 290 1.8× 120 1.4× 35 0.5× 8 1.0k
L. B. S. Gelinck Netherlands 14 406 0.7× 346 1.1× 149 0.9× 30 0.3× 41 0.6× 24 727
Bryan T. Mayer United States 15 368 0.6× 261 0.9× 73 0.4× 104 1.2× 101 1.4× 27 745
Daniele Lapa Italy 19 436 0.8× 567 1.9× 118 0.7× 157 1.8× 28 0.4× 58 1.1k

Countries citing papers authored by Rani Athota

Since Specialization
Citations

This map shows the geographic impact of Rani Athota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rani Athota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rani Athota more than expected).

Fields of papers citing papers by Rani Athota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rani Athota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rani Athota. The network helps show where Rani Athota may publish in the future.

Co-authorship network of co-authors of Rani Athota

This figure shows the co-authorship network connecting the top 25 collaborators of Rani Athota. A scholar is included among the top collaborators of Rani Athota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rani Athota. Rani Athota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Giurgea, Luca T., Alison Han, Lindsay Czajkowski, et al.. (2025). 593. Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
2.
Giurgea, Luca T., Alison Han, Lindsay Czajkowski, et al.. (2024). Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers. mBio. 15(2). e0237223–e0237223. 9 indexed citations
3.
Manning, Jessica E., Fabiano Oliveira, Iliano V. Coutinho-Abreu, et al.. (2020). Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial. The Lancet. 395(10242). 1998–2007. 45 indexed citations
4.
Han, Alison, Lindsay Czajkowski, Luz Angela Rosas, et al.. (2020). Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model. Clinical Infectious Diseases. 73(11). e4260–e4268. 36 indexed citations
5.
Memoli, Matthew J., Alison Han, Kathie‐Anne Walters, et al.. (2019). Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and “Universal” Vaccine Development. Clinical Infectious Diseases. 70(5). 748–753. 40 indexed citations
6.
Han, Alison, Luca T. Giurgea, Adriana Cervantes-Medina, et al.. (2019). 2750. Sequential Influenza A H1N1 and Influenza A H3N2 Challenge Infections in Healthy Volunteers. Open Forum Infectious Diseases. 6(Supplement_2). S969–S969. 1 indexed citations
7.
Han, Alison, Lindsay Czajkowski, Holly Ann Baus, et al.. (2019). A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model. Clinical Infectious Diseases. 69(12). 2082–2090. 42 indexed citations
8.
9.
Memoli, Matthew J., Pamela A. Shaw, Alison Han, et al.. (2016). Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model. mBio. 7(2). e00417–16. 272 indexed citations
10.
Memoli, Matthew J., Lindsay Czajkowski, Susan Reed, et al.. (2014). Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study. Clinical Infectious Diseases. 60(5). 693–702. 107 indexed citations
11.
Memoli, Matthew J., Rani Athota, Shelby D. Reed, et al.. (2013). The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts. Clinical Infectious Diseases. 58(2). 214–224. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026